Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) Income towards Parent Company (2020 - 2025)

Medicale's Income towards Parent Company history spans 5 years, with the latest figure at -$8654.0 for Q3 2025.

  • For Q3 2025, Income towards Parent Company changed N/A year-over-year to -$8654.0; the TTM value through Sep 2025 reached -$33652.0, changed N/A, while the annual FY2025 figure was -$33652.0, N/A changed from the prior year.
  • Income towards Parent Company reached -$8654.0 in Q3 2025 per MCLE's latest filing, down from -$3575.0 in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $455.0 in Q4 2022 to a low of -$14995.0 in Q4 2024.
  • Average Income towards Parent Company over 4 years is -$4686.2, with a median of -$5001.5 recorded in 2025.
  • The largest YoY upside for Income towards Parent Company was 175.83% in 2022 against a maximum downside of 90.84% in 2022.
  • A 4-year view of Income towards Parent Company shows it stood at -$600.0 in 2021, then surged by 175.83% to $455.0 in 2022, then plummeted by 3395.6% to -$14995.0 in 2024, then soared by 42.29% to -$8654.0 in 2025.
  • Per Business Quant, the three most recent readings for MCLE's Income towards Parent Company are -$8654.0 (Q3 2025), -$3575.0 (Q2 2025), and -$6428.0 (Q1 2025).